Pentosidine and increased fracture risk in older adults with type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2008-2498PMID 19383780PMCID PMC2708944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalent Vertebral Fractures in Black Women and White Women

  2008cited by this paper
• Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures

  2008cited by this paper
• The role of advanced glycation end products in progression and complications of diabetes

  2008cited by this paper
• A bone structural basis for fracture risk in diabetes.

  2008cited by this paper
• Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.

  2008cited by this paper
• High-trauma fractures and low bone mineral density in older women and men.

  2007cited by this paper
• Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis

  2007cited by this paper
• Renal function and risk of hip and vertebral fractures in older women.

  2007cited by this paper
• Non-enzymatic Glycation of Bone Collagen Modifies Osteoclastic Activity and Differentiation*

  2007cited by this paper
• Standards of medical care in diabetes--2006.

  2006cited by this paper
• Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae.

  2006cited by this paper
• Degree of Mineralization-related Collagen Crosslinking in the Femoral Neck Cancellous Bone in Cases of Hip Fracture and Controls

  2006cited by this paper
• Standards of Medical Care in Diabetes–2006

  2006cited by this paper
• Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats

  2006cited by this paper
• Advanced Glycation End Products and Bone Loss during Aging

  2005cited by this paper
• Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links.

  2005cited by this paper
• In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures

  2005cited by this paper
• Racial differences in the prevalence of vertebral fractures in older men: the Baltimore Men’s Osteoporosis Study

  2005cited by this paper
• Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study.

  2005cited by this paper
• Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix.

  2004cited by this paper
• Diabetes Is Associated Independently of Body Composition With BMD and Bone Volume in Older White and Black Men and Women: The Health, Aging, and Body Composition Study

  2004cited by this paper
• High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress.

  2003cited by this paper
• Advanced glycation end-products pentosidine and N " -carboxymethyllysine are elevated in serum of patients with osteoporosis

  2003cited by this paper
• National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

  2003cited by this paper
• Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.

  2003cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Age-related changes in the collagen network and toughness of bone.

  2002cited by this paper
• Clinical use of bone densitometry: clinical applications.

  2002cited by this paper
• Older women with diabetes have an increased risk of fracture: a prospective study.

  2001cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro

  1999cited by this paper
• Vertebral Fracture Assessment using the Lateral Scoutview of Computed Tomography in Comparison with Radiographs

  1998cited by this paper
• Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus.

  1998cited by this paper
• Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles.

  1997cited by this paper
• Direct quantification of pentosidine in urine and serum by HPLC with column switching.

  1996cited by this paper
• Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures

  1995cited by this paper
• Drug data coding and analysis in epidemiologic studies

  1994cited by this paper
• Diabetes Control and Complications Trial

  1993cited by this paper
• Vertebral fracture assessment using a semiquantitative technique

  1993cited by this paper
• Vertebral Fracture in Osteoporosis

  1993cited by this paper
• Advanced glycosylation end products in patients with diabetic nephropathy.

  1991cited by this paper

• Pentosidine as a biomarker for bone fragility: Molecular mechanisms, clinical relevance, and detection strategies.

  2026cites this paper
• Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney Disease

  2025cites this paper
• Research progress of diabetic osteoporosis: a comprehensive review

  2025cites this paper
• Advanced glycation end-product adducts alter the bone collagen network and human cortical bone fracture resistance

  2025cites this paper
• Menaquinone-7 Supplementation Increases Multiple Advanced Glycation End-Products and Oxidation Markers in Zucker Diabetic Fatty Rats

  2025cites this paper
• Brazilian guidelines for the management of osteoporosis in diabetes mellitus

  2025cites this paper
• Physiopathologie de l’atteinte osseuse du diabète

  2025cites this paper
• Fragilità ossea nel diabete: meccanismi fisiopatologici e strategie terapeutiche

  2025cites this paper
• Diabetes-Induced Osteoporosis: Dual Energy X-Ray Absorptiometry Bone Quality Is Better than Bone Quantity

  2025cites this paper
• Serum Pentosidine in Relation to Obesity in Patients with Type 2 Diabetes and Healthy Controls

  2025influential citation
• Establishment of an animal model of shaft femoral pseudoarthrosis in rabbits.

  2025cites this paper
• Impacts of Nonenzymatic Glycation Crosslinks in Bone Matrix on the Mechanosensitivity of Osteocyte

  2025cites this paper
• Dietary Advanced Glycation End Products (AGEs): A Modifiable Risk Factor in the Prevention of Chronic Diseases Associated with Aging?

  2025cites this paper
• Pathophysiology of Bone Fragility in Type 2 Diabetes Mellitus

  2025cites this paper
• RELATIONSHIP BETWEEN HOMOCYSTEINE LEVELS AND BONE QUALITY IN HEALTHY ADULTS - A SYSTEMATIC REVIEW AND META-ANALYSIS.

  2025cites this paper
• Advanced glycation end products are not associated with bone mineral density, trabecular bone score, and bone turnover markers in adults with and without type 1 diabetes: a cross-sectional study

  2024cites this paper
• A map of glycation and glycoxidation sites in collagen I of human cortical bone: Effects of sex and type 2 diabetes.

  2024cites this paper
• Association of chronic liver disease with bone diseases and muscle weakness

  2024cites this paper
• Antidiabetic Agents and Bone Quality: A Focus on Glycation End Products and Incretin Pathway Modulations

  2024cites this paper
• AGEs (Advanced Glycation End-products) in bone come of age.

  2024cites this paper
• In vivo glycation-interplay between oxidant and carbonyl stress in bone.

  2024cites this paper
• The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women with Type 2 Diabetes: a Randomized Clinical Trial.

  2024cites this paper
• Mechanistic implications of diabetes leading to bone pathology

  2024cites this paper
• Slot Blot- and Electrospray Ionization–Mass Spectrometry/Matrix-Assisted Laser Desorption/Ionization–Mass Spectrometry-Based Novel Analysis Methods for the Identification and Quantification of Advanced Glycation End-Products in the Urine

  2024cites this paper
• Urinary pentosidine as a potential biomarker of impaired bone health: a systematic review and meta-analysis

  2024influential citation
• Risk Factors for Bone Microarchitecture Impairments in Older Men with Type 2 Diabetes - The MrOS Study.

  2024cites this paper
• F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes.

  2024cites this paper
• Predicting the Occurrence of New Vertebral Fractures Using the Vertebral Bone Quality Score

  2024cites this paper
• Bone Fragility in Diabetes and its Management: A Narrative Review

  2024cites this paper
• Whole-bone toughness is linked to canal and osteocyte lacunae deficits in the ZDSD type 2 diabetic rat model

  2023cites this paper
• Diabetes and Osteoporosis

  2023cites this paper
• Investigating biochemical and structural changes of glycated collagen using multimodal multiphoton imaging, Raman spectroscopy, and atomic force microscopy

  2023cites this paper
• Advanced glycation and glycoxidation end products in bone.

  2023cites this paper
• Structural role of osteocalcin and its modification in bone fracture.

  2023cites this paper
• Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification

  2023cites this paper
• Evaluating the Effect of Jointly Administering Synthetic Graft and Ankaferd Blood Stopper for Bone Recovery in Created Bone Deformities in Diabetic Rats

  2023cites this paper
• Type 2 Diabetes and Bone Disease

  2023cites this paper
• Biochemical Markers of Bone Fragility in Patients With Diabetes

  2023cites this paper
• Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017–2018

  2023cites this paper
• Role of advanced glycation endproducts in bone fragility in type 1 diabetes.

  2023cites this paper
• Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications

  2023cites this paper
• The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD

  2023cites this paper
• Medications and medical expenditures for diabetic patients with osteoporosis in Beijing, China: A retrospective study.

  2023cites this paper
• Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study.

  2022cites this paper
• Evaluation of Quality and Bone Microstructure Alterations in Patients with Type 2 Diabetes: A Narrative Review

  2022cites this paper
• Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus

  2022cites this paper
• Association of pentosidine and homocysteine levels with number of teeth present in Japanese postmenopausal women

  2022cites this paper
• Techniques for advanced glycation end product measurements for diabetic bone disease: pitfalls and future directions

  2022cites this paper
• Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes

  2022cites this paper
• Type 2 Diabetes and Bone

  2022cites this paper
• Crosstalk Between Senescent Bone Cells and the Bone Tissue Microenvironment Influences Bone Fragility During Chronological Age and in Diabetes

  2022cites this paper
• Bone fragility in diabetes: novel concepts and clinical implications.

  2022cites this paper
• Skeletal Fragility in Type 2 Diabetes Mellitus: Bone Mechanical Properties, Microarchitecture, and Advanced Glycation End-Products in the Proximal Femur

  2022cites this paper
• High glucose-induced inhibition of osteoblast like MC3T3-E1 differentiation promotes mitochondrial perturbations

  2022cites this paper
• Dimorphic Mechanisms of Fragility in Diabetes Mellitus: the Role of Reduced Collagen Fibril Deformation

  2022influential citation
• Evaluation of the effect of metformin treatment on markers of bone formation and resorption in patients newly diagnosed with Type 2 diabetes

  2022cites this paper
• Contributors to impaired bone health in type 2 diabetes.

  2022cites this paper
• Advanced glycation end products and bone - How do we measure them and how do they correlate with bone mineral density and fractures? A systematic review and evaluation of precision of measures.

  2022cites this paper
• Glycemic Control and Bone in Diabetes

  2022cites this paper
• Human tibial cortical bone with high porosity in type 2 diabetes mellitus is accompanied by distinctive bone material properties.

  2022cites this paper
• Fracture risk assessment in diabetes mellitus

  2022cites this paper
• Accumulation of fluorescent advanced glycation end products and carboxymethyl-lysine in human cortical and trabecular bone

  2022cites this paper
• Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus

  2022cites this paper
• Bone matrix quality in a developing high-fat diet mouse model is altered by RAGE deletion.

  2022cites this paper
• Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility.

  2022cites this paper
• Diabetes and bone

  2022cites this paper
• Bone Disease and Diabetes

  2022cites this paper
• Association of Urinary Pentosidine Levels With the Risk of Fractures in Patients With Severe Osteoporosis: The Japanese Osteoporosis Intervention Trial‐05 (JOINT‐05)

  2022cites this paper
• Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease

  2021cites this paper
• Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies

  2021cites this paper
• Systematic Review: Are the Elderly With Diabetes Mellitus Type 2 Prone to Fragility Fractures?

  2021cites this paper
• Oxidative Modification of Proteins: From Damage to Catalysis, Signaling, and Beyond

  2021cites this paper
• Diabetes, diabetic medications, and risk of fracture

  2021cites this paper
• The nature of osteoporosis

  2021cites this paper
• Skin autofluorescence Is associated With low bone mineral density in type 2 diabetic patients.

  2021cites this paper
• Greater Carboxy‐Methyl‐Lysine Is Associated With Increased Fracture Risk in Type 2 Diabetes

  2021cites this paper
• Increased Urinary Levels of Pentosidine Measured by a Newly Developed Enzyme-Linked Immunosorbent Assay Are Independently Correlated with Fracture After Fall

  2021cites this paper
• Роль конечных продуктов гликирования в развитии и прогрессировании диабетической нейроостеоартропатии

  2021cites this paper
• Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.

  2021cites this paper
• Prevalence of osteoporosis and osteoporotic fractures in postmenopausal women with type 2 diabetes mellitus

  2021cites this paper
• Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus

  2021cites this paper
• Biochemical markers of bone turnover in osteoporosis

  2021cites this paper
• Advanced glycation endproducts and bone quality: practical implications for people with type 2 diabetes

  2021cites this paper
• Type 2 diabetes mellitus and the risk of hip and vertebral fractures: a systematic review and meta-analysis of cohort studies

  2021cites this paper
• Development of a novel atrophic non-union model in rabbits: A preliminary study

  2021cites this paper
• Effects of Incretin-Related Diabetes Drugs on Bone Formation and Bone Resorption

  2021cites this paper
• BLOOD SUGAR REDUCING POTENTIALS AND HEAMATOLOGICAL PARAMETERS OF TURMERIC (CURCUMA LONGA) IN ALLOXAN-INDUCED DIABETIC ALBINO RAT (RATTUS NORVEGICUS)

  2021cites this paper
• Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel.

  2021cites this paper
• Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes

  2021cites this paper
• Non‐Obese MKR Mouse Model of Type 2 Diabetes Reveals Skeletal Alterations in Mineralization and Material Properties

  2021cites this paper
• Bone Homeostasis and Therapeutic Implications of Sclerostin in Type 2 Diabetics

  2020cites this paper
• Diabetes mellitus 2 . typu a kvalita kosti Type 2 diabetes mellitus and bone quality

  2020cites this paper
• Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers

  2020cites this paper
• Diabetes mellitus: How being too sweet leads to skeletal fragility

  2020cites this paper
• Effects of denosumab treatment in chronic liver disease patients with osteoporosis

  2020cites this paper
• Postmenapozal Tip-2 diyabetes mellitus’lu hastalarda osteoporoza bağlı kırık riskinin ve kemik Turnoveri’nin değerlendirilmesi

  2020cites this paper
• Current Knowledge Regarding the Interaction Between Oral Bone Metabolic Disorders and Diabetes Mellitus

  2020influential citation
• Diabetes mellitus—Infections and fracture healing

  2020cites this paper
• Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes

  2020cites this paper
• Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study

  2020cites this paper